(REG) Regency Centers - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7588491032
Stock: Retail, Grocery-Anchored, Shopping, Centers, REIT
Total Rating 45
Risk 55
Buy Signal 0.40
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.06% |
| Yield on Cost 5y | 7.16% |
| Yield CAGR 5y | 4.46% |
| Payout Consistency | 98.1% |
| Payout Ratio | 102.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 19.0% |
| Relative Tail Risk | -0.92% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.25 |
| Alpha | -2.78 |
| Character TTM | |
|---|---|
| Beta | 0.512 |
| Beta Downside | 0.541 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.53% |
| CAGR/Max DD | 0.55 |
Description: REG Regency Centers January 03, 2026
Regency Centers (NASDAQ: REG) is a nationally-focused REIT that owns, operates, and develops suburban shopping centers anchored by high-traffic grocery, restaurant, and service tenants. The company markets itself as a fully integrated, self-administered real-estate platform and is a member of the S&P 500.
Key operating metrics that signal its current performance include an FY 2023 occupancy rate of roughly 96%, funds-from-operations (FFO) of $5.60 per share, and a dividend yield near 5.2%, all of which are above the median for the Retail REIT sub-industry.
Sector-level drivers that shape Regency’s outlook are the continued strength of suburban grocery demand-fuelled by demographic trends toward higher-income, family-oriented households-and the relative resilience of essential-services retail to e-commerce displacement. However, rising interest rates and inflation-linked construction costs remain material headwinds for new development pipelines.
For a deeper, data-driven analysis of REG’s valuation and risk profile, you might explore the detailed metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 629.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.34 > 1.0 |
| NWC/Revenue: 26.23% < 20% (prev -8.22%; Δ 34.46% < -1%) |
| CFO/TA 0.06 > 3% & CFO 815.1m > Net Income 629.7m |
| Net Debt (5.82b) to EBITDA (1.07b): 5.41 < 3 |
| Current Ratio: 5.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (183.1m) vs 12m ago 0.72% < -2% |
| Gross Margin: 60.52% > 18% (prev 0.71%; Δ 5980 % > 0.5%) |
| Asset Turnover: 13.26% > 50% (prev 12.13%; Δ 1.13% > 0%) |
| Interest Coverage Ratio: 4.46 > 6 (EBITDA TTM 1.07b / Interest Expense TTM 152.7m) |
Altman Z'' -0.27
| A: 0.03 (Total Current Assets 531.4m - Total Current Liabilities 89.7m) / Total Assets 13.00b |
| B: -0.15 (Retained Earnings -1.99b / Total Assets 13.00b) |
| C: 0.05 (EBIT TTM 680.7m / Avg Total Assets 12.70b) |
| D: -0.34 (Book Value of Equity -1.99b / Total Liabilities 5.82b) |
| Altman-Z'' Score: -0.27 = B |
Beneish M -2.88
| DSRI: 0.90 (Receivables 273.9m/271.8m, Revenue 1.68b/1.50b) |
| GMI: 1.18 (GM 60.52% / 71.19%) |
| AQI: 0.99 (AQ_t 0.93 / AQ_t-1 0.95) |
| SGI: 1.12 (Revenue 1.68b / 1.50b) |
| TATA: -0.01 (NI 629.7m - CFO 815.1m) / TA 13.00b) |
| Beneish M-Score: -2.88 (Cap -4..+1) = A |
What is the price of REG shares?
As of February 08, 2026, the stock is trading at USD 75.22 with a total of 2,235,145 shares traded.
Over the past week, the price has changed by +3.22%, over one month by +8.04%, over three months by +10.69% and over the past year by +7.36%.
Over the past week, the price has changed by +3.22%, over one month by +8.04%, over three months by +10.69% and over the past year by +7.36%.
Is REG a buy, sell or hold?
Regency Centers has received a consensus analysts rating of 4.25.
Therefore, it is recommended to buy REG.
- StrongBuy: 10
- Buy: 5
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the REG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 79.4 | 5.6% |
| Analysts Target Price | 79.4 | 5.6% |
| ValueRay Target Price | 82.1 | 9.1% |
REG Fundamental Data Overview February 07, 2026
P/E Trailing = 26.8643
P/E Forward = 30.6748
P/S = 8.7771
P/B = 2.0664
P/EG = 2.7008
Revenue TTM = 1.68b USD
EBIT TTM = 680.7m USD
EBITDA TTM = 1.07b USD
Long Term Debt = 4.89b USD (from longTermDebt, two quarters ago)
Short Term Debt = 360.7m USD (from shortTermDebt, last quarter)
Debt = 5.94b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.82b USD (from netDebt column, last quarter)
Enterprise Value = 19.66b USD (13.84b + Debt 5.94b - CCE 120.7m)
Interest Coverage Ratio = 4.46 (Ebit TTM 680.7m / Interest Expense TTM 152.7m)
EV/FCF = 24.11x (Enterprise Value 19.66b / FCF TTM 815.1m)
FCF Yield = 4.15% (FCF TTM 815.1m / Enterprise Value 19.66b)
FCF Margin = 48.41% (FCF TTM 815.1m / Revenue TTM 1.68b)
Net Margin = 37.40% (Net Income TTM 629.7m / Revenue TTM 1.68b)
Gross Margin = 60.52% ((Revenue TTM 1.68b - Cost of Revenue TTM 664.8m) / Revenue TTM)
Gross Margin QoQ = 55.22% (prev 44.49%)
Tobins Q-Ratio = 1.51 (Enterprise Value 19.66b / Total Assets 13.00b)
Interest Expense / Debt = 0.90% (Interest Expense 53.3m / Debt 5.94b)
Taxrate = 21.0% (US default 21%)
NOPAT = 537.7m (EBIT 680.7m * (1 - 21.00%))
Current Ratio = 5.92 (Total Current Assets 531.4m / Total Current Liabilities 89.7m)
Debt / Equity = 0.86 (Debt 5.94b / totalStockholderEquity, last quarter 6.91b)
Debt / EBITDA = 5.41 (Net Debt 5.82b / EBITDA 1.07b)
Debt / FCF = 7.14 (Net Debt 5.82b / FCF TTM 815.1m)
Total Stockholder Equity = 6.77b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.96% (Net Income 629.7m / Total Assets 13.00b)
RoE = 9.30% (Net Income TTM 629.7m / Total Stockholder Equity 6.77b)
RoCE = 5.84% (EBIT 680.7m / Capital Employed (Equity 6.77b + L.T.Debt 4.89b))
RoIC = 4.76% (NOPAT 537.7m / Invested Capital 11.29b)
WACC = 5.67% (E(13.84b)/V(19.78b) * Re(7.80%) + D(5.94b)/V(19.78b) * Rd(0.90%) * (1-Tc(0.21)))
Discount Rate = 7.80% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.50%
[DCF Debug] Terminal Value 86.55% ; FCFF base≈733.6m ; Y1≈749.5m ; Y5≈828.4m
Fair Price DCF = 103.0 (EV 24.65b - Net Debt 5.82b = Equity 18.83b / Shares 182.9m; r=5.90% [WACC]; 5y FCF grow 2.03% → 2.90% )
EPS Correlation: -1.69 | EPS CAGR: -0.96% | SUE: 4.0 | # QB: 1
Revenue Correlation: 89.82 | Revenue CAGR: 13.40% | SUE: 1.43 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.62 | Chg30d=+0.011 | Revisions Net=+1 | Analysts=3
EPS current Year (2026-12-31): EPS=2.42 | Chg30d=+0.005 | Revisions Net=+1 | Growth EPS=-14.3% | Growth Revenue=+7.2%
EPS next Year (2027-12-31): EPS=2.58 | Chg30d=+0.000 | Revisions Net=+2 | Growth EPS=+6.5% | Growth Revenue=+1.7%
P/E Forward = 30.6748
P/S = 8.7771
P/B = 2.0664
P/EG = 2.7008
Revenue TTM = 1.68b USD
EBIT TTM = 680.7m USD
EBITDA TTM = 1.07b USD
Long Term Debt = 4.89b USD (from longTermDebt, two quarters ago)
Short Term Debt = 360.7m USD (from shortTermDebt, last quarter)
Debt = 5.94b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.82b USD (from netDebt column, last quarter)
Enterprise Value = 19.66b USD (13.84b + Debt 5.94b - CCE 120.7m)
Interest Coverage Ratio = 4.46 (Ebit TTM 680.7m / Interest Expense TTM 152.7m)
EV/FCF = 24.11x (Enterprise Value 19.66b / FCF TTM 815.1m)
FCF Yield = 4.15% (FCF TTM 815.1m / Enterprise Value 19.66b)
FCF Margin = 48.41% (FCF TTM 815.1m / Revenue TTM 1.68b)
Net Margin = 37.40% (Net Income TTM 629.7m / Revenue TTM 1.68b)
Gross Margin = 60.52% ((Revenue TTM 1.68b - Cost of Revenue TTM 664.8m) / Revenue TTM)
Gross Margin QoQ = 55.22% (prev 44.49%)
Tobins Q-Ratio = 1.51 (Enterprise Value 19.66b / Total Assets 13.00b)
Interest Expense / Debt = 0.90% (Interest Expense 53.3m / Debt 5.94b)
Taxrate = 21.0% (US default 21%)
NOPAT = 537.7m (EBIT 680.7m * (1 - 21.00%))
Current Ratio = 5.92 (Total Current Assets 531.4m / Total Current Liabilities 89.7m)
Debt / Equity = 0.86 (Debt 5.94b / totalStockholderEquity, last quarter 6.91b)
Debt / EBITDA = 5.41 (Net Debt 5.82b / EBITDA 1.07b)
Debt / FCF = 7.14 (Net Debt 5.82b / FCF TTM 815.1m)
Total Stockholder Equity = 6.77b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.96% (Net Income 629.7m / Total Assets 13.00b)
RoE = 9.30% (Net Income TTM 629.7m / Total Stockholder Equity 6.77b)
RoCE = 5.84% (EBIT 680.7m / Capital Employed (Equity 6.77b + L.T.Debt 4.89b))
RoIC = 4.76% (NOPAT 537.7m / Invested Capital 11.29b)
WACC = 5.67% (E(13.84b)/V(19.78b) * Re(7.80%) + D(5.94b)/V(19.78b) * Rd(0.90%) * (1-Tc(0.21)))
Discount Rate = 7.80% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.50%
[DCF Debug] Terminal Value 86.55% ; FCFF base≈733.6m ; Y1≈749.5m ; Y5≈828.4m
Fair Price DCF = 103.0 (EV 24.65b - Net Debt 5.82b = Equity 18.83b / Shares 182.9m; r=5.90% [WACC]; 5y FCF grow 2.03% → 2.90% )
EPS Correlation: -1.69 | EPS CAGR: -0.96% | SUE: 4.0 | # QB: 1
Revenue Correlation: 89.82 | Revenue CAGR: 13.40% | SUE: 1.43 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.62 | Chg30d=+0.011 | Revisions Net=+1 | Analysts=3
EPS current Year (2026-12-31): EPS=2.42 | Chg30d=+0.005 | Revisions Net=+1 | Growth EPS=-14.3% | Growth Revenue=+7.2%
EPS next Year (2027-12-31): EPS=2.58 | Chg30d=+0.000 | Revisions Net=+2 | Growth EPS=+6.5% | Growth Revenue=+1.7%